Nkarta, Inc. (NKTX)
3.145
-0.18
(-5.27%)
USD |
NASDAQ |
May 07, 16:00
3.145
0.00 (0.00%)
After-Hours: 20:00
Nkarta EPS Diluted (Quarterly) : -0.3702 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Inovio Pharmaceuticals, Inc. | 0.0546 |
| ADMA Biologics, Inc. | 0.2025 |
| Cullinan Therapeutics, Inc. | -0.8566 |
| Zenas BioPharma, Inc. | -5.172 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.41M |
| Total Expenses (Quarterly) | 27.41M |
| Enterprise Value | 36.83M |
| Earnings Yield | -44.73% |
| Normalized Earnings Yield | -44.73 |